P53 mutations analysis in benign and malignant breast lesions: Using needle rinses from fine‐needle aspirations

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Diagnostic Cytopathology

• Publication date

  2000-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/(SICI)1097-0339(200005)22:5<268::AID-DC2>3.0.CO;2-XPMID 10790231
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular genetic studies of early breast cancer evolution

  2004cited by this paper
• Prognostic significance of p53 gene alterations in node-negative breast cancer

  2004cited by this paper
• Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci.

  1998cited by this paper
• Immunohistochemical detection of c-erbB-2 and p53 in benign breast disease and breast cancer risk.

  1998cited by this paper
• The molecular epidemiology of p53 gene mutations in human breast cancer.

  1997cited by this paper
• Genomic instability and poor prognosis associated with abnormal TP53 in breast carcinomas. Molecular and immunohistochemical analysis

  1997cited by this paper
• Molecular and immunohistochemical analysis of p53 mutations in scrapings and tissue from preinvasive and invasive breast cancer

  1997cited by this paper
• Loss of heterozygosity and microsatellite instability in breast hyperplasia. No obligate correlation of these genetic alterations with subsequent malignancy.

  1997cited by this paper
• Breast cytology and biomarkers obtained by random fine needle aspiration: Use in risk assessment and early chemoprevention trials

  1997cited by this paper
• Loss of Heterozygosity in Normal Tissue Adjacent to Breast Carcinomas

  1996cited by this paper
• Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value.

  1996cited by this paper
• TP53 mutation analyses on breast carcinomas: a study of paraffin-embedded archival material.

  1996cited by this paper
• Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

  1996cited by this paper
• p53 accumulation in benign breast biopsy specimens.

  1995cited by this paper
• Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p.

  1995cited by this paper
• Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy

  1995cited by this paper
• TP53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc‐binding domains

  1995cited by this paper
• TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis.

  1995cited by this paper
• p53 mutations in benign breast tissue.

  1995cited by this paper
• Diagnostic associations of p53 immunostaining in fine needle aspiration cytology of the breast

  1994cited by this paper
• Problems with p53 immunohistochemical staining: the effect of fixation and variation in the methods of evaluation.

  1994cited by this paper
• Chromosomal aneuploidy in proliferative breast disease.

  1994cited by this paper
• Long-term risk of breast cancer in women with fibroadenoma.

  1994cited by this paper
• Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor.

  1993cited by this paper
• Prognostic significance of TP53 alterations in breast carcinoma.

  1993cited by this paper
• Prevention of pre-PCR mis-priming and primer dimerization improves low-copy-number amplifications.

  1992cited by this paper
• Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations.

  1991cited by this paper
• p53 expression in cytologic specimens from benign and malignant breast lesions.

  1991cited by this paper
• Risk factors for breast cancer in women with proliferative breast disease.

  1985cited by this paper
• Atypical hyperplastic lesions of the female breast. A long‐term follow‐up study

  1985cited by this paper
• The cellular protein p53 in human tumours.

  1984cited by this paper

• Differences in somatic TP53 mutation type in breast tumors by race and receptor status

  2021cites this paper
• The role of ThinPrep cytology in the investigation of ki-67 index, p53 and HER-2 detection in fine-needle aspirates of breast tumors.

  2013cites this paper
• Quantitative Analysis of C-erbB2 and P53 Protein Levels in Breast Tumor Tissues and Study of Their Associations with Tumor biological Characteristics and Prognosis

  2013cites this paper
• Cytogenetic polyclonality of breast carcinomas : Association with Clinico‐Pathological Characteristics and Outcome

  2011cites this paper
• Evaluation of apoptosis in cytologic specimens

  2010cites this paper
• Chromosomal alterations and telomere dysfunction in breast tumours

  2008cites this paper
• Aurora-A amplification associated with BRCA2 mutation in breast tumours.

  2007cites this paper
• MYC amplification and TERT expression in breast tumor progression.

  2007cites this paper
• Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer

  2006cites this paper
• Effect of hypoxia and TP53 mutation status and cytogenetics of normal and malignant mammary epithelium.

  2006cites this paper
• p53 Alterations and Protein Accumulation in Benign Breast Tissue and Breast Cancer Risk: A Cohort Study

  2006cites this paper
• Evaluation of oligonucleotide arrays for sequencing of the p53 gene in DNA from formalin-fixed, paraffin-embedded breast cancer specimens.

  2004cites this paper
• Detection of gene promoter hypermethylation in fine needle washings from breast lesions.

  2003cites this paper
• Oral lichen planus has a high rate of TP53 mutations. A study of oral mucosa in icelanD.

  2002cites this paper
• Increased yield of total RNA from fine-needle aspirates for use in expression microarray analysis.

  2002cites this paper
• p53 Mutations as Tumor Markers in Fine Needle Aspirates of Palpable Breast Masses

  2002cites this paper
• [Cytopathology--current trends].

  2001cites this paper
• Differential p53 protein expression in breast cancer fine needle aspirates: the potential for in vivo monitoring

  2001cites this paper
• GSTM1, GSTT1, and GSTP1 genotypes in relation to breast cancer risk and frequency of mutations in the p53 gene.

  2001cites this paper
• GSTM 1 , GSTT 1 , and GSTP 1 Genotypes in Relation to Breast Cancer Risk and Frequency of Mutations in the p 53 Gene 1

  2001cites this paper
• p53 abnormality and chromosomal instability in the same breast tumor cells.

  2000cites this paper